The efficacy and safety of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis

BACKGROUND: We aim to assess the efficacy and safety profiles of immune checkpoint inhibitors in patients with metastatic castration-resistant prostate cancer using a meta-analysis. METHODS: We extracted and examined data from phase I, II and III clinical trials from PubMed, Embase, Web of Science,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xing-Hui, Wang, Zhi-Qiang, Mu, Zhen-Yu, Zhu, Li-Ping, Zhong, Chong-Fu, Guo, Shanchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351907/
https://www.ncbi.nlm.nih.gov/pubmed/35945714
http://dx.doi.org/10.1097/MD.0000000000029715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351907/
https://www.ncbi.nlm.nih.gov/pubmed/35945714
http://dx.doi.org/10.1097/MD.0000000000029715

Ejemplares similares